Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Tcr2 Therapeutics Inc (TCRR)

Tcr2 Therapeutics Inc (TCRR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Tcr2 Therapeutics Inc 100 BINNEY STREET SUITE 710 CAMBRIDGE MA 02142 USA

www.tcr2.com P: 617-949-5200

Description:

TCR2 Therapeutics Inc. is a clinical-stage immunotherapy company developing T cell therapies for patients suffering from cancer. Its product candidate includes TC-210, TC-220, TC-410, TC-110 and TC-310 which are in clinical stage. TCR2 Therapeutics Inc. is based in Cambridge, Massachusetts.

Key Statistics

Overview:

Market Capitalization, $K 58,108
Enterprise Value, $K -91,072
Shares Outstanding, K 39,262
Annual Sales, $ 0 K
Annual Net Income, $ -151,820 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -40,400 K
60-Month Beta 1.94
% of Insider Shareholders 25.01%
% of Institutional Shareholders 64.76%
Float, K 29,443
% Float 74.99%
Short Volume Ratio 0.54

Growth:

1-Year Return -35.65%
3-Year Return -88.47%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.03 on 05/11/23
Next Earnings Date N/A
Earnings Per Share ttm -4.20
EPS Growth vs. Prev Qtr 33.97%
EPS Growth vs. Prev Year -35.53%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

TCRR Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -97.81%
Return-on-Assets % -69.35%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.57
Book Value/Share 2.58
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar